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Immunoglobulin (Ig) class switching can occur in the absence of ah+ or gy+ T cells when mice are infected with certain live viruses,
although CD4 T helper cells are believed to be essential for induction of a high-affinity antibody response and for efficient isotype switching
from IgM to IgG and IgA production. However, little information is available about the immune responses after mucosal immunization of
CD4+ T cell-deficient mice with inactivated virus. In this study, we show that intranasal immunization with formalin-inactivated influenza
A/PR8/34 virus induces IgG and IgA responses in serum and IgA responses in mucosal secretions in CD4+ T cell-deficient mice. All four
subclasses of IgG were produced. IgG1/IgG2a ratios were found to be from 1 to 1.75, indicating that both Th1 and Th2 immune responses
are induced by the inactivated influenza virus. The sera and mucosal secretions were found to have neutralizing activity against influenza
virus in vitro. In addition, the mucosally immunized CD4+ T cell-deficient mice were protected completely from challenge with a lethal dose
of live, pathogenic influenza virus. To our knowledge, this is the first demonstration that mucosal immunization with an inactivated virus
induces immune responses in serum and mucosal secretions in CD4+ T cell-deficient mice.
D 2004 Elsevier Inc. All rights reserved.
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CD4+ T cells are believed to play a critical role in the
regulation of immunoglobulin (Ig) class switching during an
immune response (Bachmann and Zinkernagel, 1996;
Oxenius et al., 1998; Parker, 1993). CD4+ T cells can help
B cells through two distinct pathways: (1) cognate help for
B cells by promoting B-cell activation and Ig isotype
switching by direct T–B cell interaction; (2) noncognate or
bystander help mediated by the cytokines secreted by the
activated CD4+ T cells. It is well established that three
cytokines, interleukin 4 (IL-4), gamma-interferon (IFN-g),
and transforming growth factor beta (TGF-h), play prom-
inent roles in regulating Ig class switching (Snapper and
Mond, 1993). In vitro, IL-4 was found to stimulate the0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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90095.production of IgG1 and IgE selectively (Coffman and Carty,
1986; Isakson et al., 1982); IFN-g can initiate Ig class
switching to IgG2a and IgG3 (McIntyre et al., 1993; Rose et
al., 1998; Snapper and Paul, 1987); and TGF-h can
specifically enhance the production of IgG2b and IgA
(McIntyre et al., 1993; Sonoda et al., 1989). These findings
have also been confirmed by in vivo studies (Finkelman et
al., 1988, 1990; Schurmans et al., 1990).
The idea that Ig class switching is a CD4+ T cell-
dependent process has been challenged recently by the
finding that this process can occur in the absence of ah+ T
cells (Szomolanyi-Tsuda and Welsh, 1998; Szomolanyi-
Tsuda et al., 1998). Polyomavirus (PyV) infection of
TCRh/ or TCRhxy/ mice, which lack functional ah+
T cells or ah+ and gy+ T cells, respectively, induced IgM
and IgG antiviral antibodies; in contrast, noninfectious
polyoma virus-like particles or purified viral proteins did
not elicit Ig class switching (Szomolanyi-Tsuda and Welsh,
1996, 1998). Studies with vesicular stomatitis virus (VSV)
in ah+ T cell-deficient mice have also shown that IgG05) 387–395
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recombinant vaccinia virus expressing the VSV glycopro-
tein, but not by immunization with formalin-inactivated
virus (Bachmann et al., 1993, 1994, 1995; Maloy et al.,
1998). Our previous study has shown that systemic
immunization with inactivated influenza virus can also
induce IgG responses in mice in the absence of CD4+ T cells
(Sha and Compans, 2000). However, little is known about
the ability of inactivated viruses to induce immune
responses in serum and mucosal sites after mucosal
immunization of immunodeficient mice in the absence of
CD4+ T helper cells or ah+ T cells.
In this study, we used formalin-inactivated influenza
A/PR8/34 virus as an immunogen and investigated the
induction of systemic and local mucosal immune
responses in serum and mucosal secretions in CD4+ T
cell-deficient mice after intranasal immunization. In
addition to evaluating IgG and IgA responses in serum
and IgA responses in saliva and vaginal secretions in mice
lacking CD4+T cells, we determined neutralizing activity
in vitro and protection against challenge with a lethal dose
of influenza virus.Fig. 1. Magnitude and isotype profiles of serum antibody responses to intranasal
immunocompetent mice. CD4+ T cell-deficient mice (16–20 weeks old) or C57BL
day 0 and boosted at days 15 and 25 with 50 or 10 Ag/mouse of inactivated in
mice. CD4/50, CD4+ T cell-deficient mice immunized with 50 Ag of inactivated i
10 Ag of inactivated influenza virus, known to be sufficient for induction of iso
Prime, samples were collected 15 days after the first immunization. Boost, samp
collected 10 days after the second boost. Statistical analysis was performed by t
mice in a group.Results
Inactivated influenza virus induces
CD4+ T cell-independent IgG and IgA responses after
intranasal immunization
We compared systemic antibody responses (IgM, IgG,
and IgA) after mucosal immunization with inactivated PR8
virus in groups of CD4+ T cell-deficient mice and C57BL/6
immunocompetent mice (Fig. 1). Both groups were
immunized with three doses of inactivated PR8 virus
intranasally at days 0, 15, and 25. The magnitude of virus-
specific IgG and IgA antibodies in sera after each
immunization was determined by an ELISA assay. IgM
responses, which are considered to be T cell-independent
(Bachmann et al., 1993, 1994, 1995), were induced in
both CD4+ T cell-deficient mice and C57BL/6. However,
levels of IgM did not show significant increases after
boost immunizations (ranging from 4.7 F 1.15 to 3.5 F
0.5 Ag/ml for CD4/ vs. 5.5 F 0.2 to 7.2 F 2.4 Ag/ml
for wild type) and differences in IgM levels were not
statistically significant between CD4+ T cell-deficient andimmunization with inactivated influenza virus in CD4+ T cell-deficient or
/6-immunocompetent mice (10 weeks old) were immunized intranasally at
fluenza virus, respectively. CD4/Con, unimmunized CD4+ T cell-deficient
nfluenza virus. BL6/10, C57BL/6-immunocompetent mice immunized with
type switching of antibodies in wild-type mice (Sha and Compans, 2000).
les were collected 10 days after the first boost. 2nd boost, samples were
he Microsoft Excel program and standard error bars are indicated for five
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also induced in both groups, indicating that antibody class
switching from IgM to IgG and IgA occurred in CD4+ T
cell-deficient mice after intranasal immunization with the
inactivated virus. All four subtypes of IgG were observed
in both groups. In contrast to IgM, the levels of IgG1,
IgG2a, IgG2b, and IgA responses were significantly
higher in C57BL/6 mice than in CD4+ T cell-deficient
mice (87 F 8.3 vs. 34.7 F 21.5 Ag/ml for IgG1, 58 F
14.8 vs. 21.0 F 4.3 Ag/ml for IgG2a, 53 F 8.1 vs. 9.4 F
1.3 Ag/ml for IgG2b, 6.7F2.4 vs. 1.6 F 1.2 Ag/ml for
IgA; all P b 0.05), suggesting that although CD4+ T cells
are not essential for this process, they can enhance those
responses significantly. In contrast, IgG3 levels were
found to be comparable in both groups (Fig. 1). These
data indicate that intranasal immunization with inactivated
PR8 virus can induce Ig class switching to IgG and IgA in
mice, and that these responses are independent of the
presence of CD4+ T cells.
In wild-type mice, intranasal immunization with 10 Ag
of inactivated influenza virus antigen was sufficient to
induce isotype switching of antibodies (Fig. 1). However,Fig. 2. Dose dependence of serum antibody responses to intranasal immunization
deficient mice (16–20 weeks old) were immunized intranasally at day 0 and boo
inactivated influenza virus. Prime, samples were collected 15 days after the first im
boost, samples were collected 10 days after the second boost. Standard error barsthe IgG and IgA responses after intranasal immunization
in CD4-deficient mice were found to be dependent upon
the quantity of the immunogen administered, as deter-
mined by the magnitude of the IgG and IgA responses in
sera (Figs. 1 and 2). Although similar levels of IgA were
observed in groups of mice that received 10 and 50 Ag of
inactivated PR8 virus, only the 50-Ag group of CD4-
deficient mice developed significant levels of all four
subtypes of IgG antibody. The levels of IgG and IgA
responses were also dependent upon the number of doses
administered in CD4-deficient mice. The first boost
immunization with 50 Ag of inactivated influenza virus
induced low levels of IgG and IgA in CD4-deficient mice.
However, the second boost increased the IgG and IgA
responses significantly in the 50-Ag group, with antibody
levels averaging 3-fold higher than those observed after
the first boost. These findings are similar to the results of
other studies showing that three immunizations are
necessary to induce IgA responses in mucosal secretions
(Di Tommaso et al., 1996). These data indicate that, in
inducing IgG and IgA responses by intranasal immuniza-
tion, CD4+ T cell-deficient mice are more dependent onwith inactivated influenza virus in CD4+ T cell-deficient mice. CD4+ T cell-
sted at days 15 and 25 with the same dose using 1, 10, or 50 Ag/mouse of
munization. Boost, samples were collected 10 days after the first boost. 2nd
are indicated for five mice in a group.
Fig. 3. Virus-neutralizing antibody activities in sera of CD4+ T cell-
deficient mice. CD4+ T cell-deficient mice were intranasally immunized
with formalin-inactivated influenza virus (10 or 50 Ag/mouse per dose) at
day 0 and boosted at days 15 and 25 with the same dose. Different
dilutions of sera from immunized mice (pooled sera from five mice in a
group) were incubated with approximately 100 plaque forming unit of
PR8 virus for 1 h at room temperature. The mixtures were then applied
to monolayers of confluent MDCK cells and a standard plaque reduction
assay was performed. Representative data are shown from two
independent experiments. CD4/Con, sera from unimmunized CD4+ T
cell-deficient mice. CD4/10/1, CD4+ T cell-deficient mice after first boost
with 10 Ag/mouse per dose. CD4/10/2, CD4+ T cell-deficient mice after
second boost with 10 Ag/mouse per dose. CD4/50/1, CD4+ T cell-
deficient mice after first boost with 50 Ag/mouse per dose. CD4/50/2,
CD4+ T cell-deficient mice after second boost with 50 Ag/mouse per
dose. BL6/10/1, C57/BL/6-immunocompetent mice after intranasal pri-
ming with 10 Ag/mouse.
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administrations than wild-type mice.
Different antigens often lead to the development of
preferential immune responses, that is, Th1 vs. Th2
responses (Mosmann and Coffman, 1989). Ratios of IgG1/
IgG2a have been used to indicate the dominance of a Th1 or
Th2 type response; Th1 responses are dominated by the
production of IgG2a, while IgG1 is associated with a Th2-
dominant responses (Mosmann and Coffman, 1989). We
found that IgG1/IgG2a ratios were from 1 to 1.75 after three
immunizations in both immunocompetent C57BL/6 mice
and CD4+ T cell-deficient mice, indicating that balanced
Th1 vs. Th2 immune responses were induced by the
inactivated PR8 virus in both groups.
Lack of immunoglobulin class switching in ab
T cell-deficient mice
The ability of CD4+ T cell-deficient mice to generate
these IgG responses was not found to be impaired when
these mice were depleted of CD8+ T cells by treatment with
an anti-CD8 mAb (Sha and Compans, 2000). To determine
if isotype class switching occurred in the absence of ah T
cells, we immunized ah+ T cell-deficient mice (TCRh/)
intranasally with 50 Ag of PR8 virus three times. Compared
to responses induced in CD4-deficient mice, only border-
line levels of serum IgG and IgA responses could be
detected in TCRh/ mice (IgG1, IgG2a b 2 Ag/ml in
TCRh/ mice vs. 21–34 Ag/ml in CD4/ mice; IgG2b,
IgG3, IgA b 0.5 Ag/ml in TCRh/ mice vs. 1.6–9.4
Ag/ml in CD4/ mice). This result is consistent with a
previous study on systemic immunization (Sha and
Compans, 2000).
Intranasal immunization with inactivated PR8 virus induces
neutralizing antibodies in sera of CD4+ T cell-deficient mice
To test whether the sera of mice have neutralizing
activity after intranasal immunization with inactivated
PR8 virus, a standard plaque reduction assay was
performed with MDCK cells. Approximately 100 plaque
forming units of influenza PR8 virus was incubated with
serial dilutions of sera from immunized mice and then
applied to confluent MDCK cell monolayers. The
numbers of plaques were counted after 4 days and
compared with those observed using sera of unimmunized
mice (Fig. 3). The groups immunized with 50 Ag had
higher neutralizing titers than the groups immunized with
10 Ag, and the sera after the second boost were found to
have higher titers than those after the first boost. The
neutralizing titer of the 50-Ag group after the second
boost was about 1:500, whereas that from the 10-Ag
group after the first boost was less than 1:20. These data
indicate that intranasal immunization with inactivated PR8
virus induces virus-neutralizing activity in sera of CD4+ T
cell-deficient mice.Mucosal immunization with inactivated PR8 virus elicits
IgA responses in mucosal secretions
Groups of CD4+ T cell-deficient mice and C57BL/6
immunocompetent mice were immunized with three doses
of inactivated PR8 virus intranasally at days 0, 15, and 25,
and the magnitude of virus-specific IgA antibodies after
each immunization in mucosal secretions was monitored
by measuring PR8-specific IgA concentrations by ELISA
(Fig. 4). IgA responses were found to be induced in saliva
(Fig. 4A) and vaginal secretions (Fig. 4B) both in C57BL/
6 immunocompetent mice and CD4+ T cell-deficient mice.
The IgA levels in saliva and vaginal secretions in the
CD4+ T cell-deficient mice were more than 10-fold higher
after three immunizations than those observed after two
immunizations. The levels of IgA responses were also
found to be dose dependent in the CD4+ T cell-deficient
mice in saliva (Fig. 5A) and vaginal secretions (Fig. 5B).
Significant increases in virus-specific IgA responses were
found in the 50-Ag group in both saliva and vaginal
secretions, as well as in saliva in the 10-Ag group after
three immunizations (Fig. 5B). These results demonstrate
that IgA responses in mucosal secretions are induced by
Fig. 5. Dose dependence of IgA responses in mucosal secretions to
intranasal immunization with inactivated influenza virus in CD4+ T cell-
deficient mice. CD4+ T cell-deficient mice (16–20 weeks old) or C57BL/6
mice (10 weeks old) were immunized intranasally and samples collected as
described in Fig. 2. (A) Saliva. (B) Vaginal secretions. Standard error bars
are indicated for five mice in a group.
Fig. 4. Magnitude of IgA responses in mucosal secretions to intranasal
immunization with inactivated influenza virus in CD4+ T cell-deficient or
immunocompetent mice. CD4+ T cell-deficient mice (16–20 weeks old) or
C57BL/6 mice (10 weeks old) were immunized intranasally (five mice per
group) at day 0 and boosted at days 15 and 25 with 50 or 10 Ag/mouse of
inactivated influenza virus, respectively. CD4/Con, unimmunized CD4+ T
cell-deficient mice. CD4/50, CD4+ T cell-deficient mice immunized with 50
Ag of inactivated PR8 virus per dose. BL6/10, C57BL/6-immunocompetent
mice immunized with 10 Ag inactivated PR8 virus per dose. (A) Saliva. (B)
Vaginal secretions. Standard error bars are indicated for five mice in a group.
Z. Sha et al. / Virology 331 (2005) 387–395 391intranasal immunization with inactivated influenza virus in
CD4+ T cell-deficient mice.
Neutralizing activities are induced in mucosal secretions in
CD4+ T cell-deficient mice
Evidence has been obtained that IgA responses at
mucosal surfaces are important for prevention of viral
infections that are initiated at mucosal surfaces (Renegar
and Small, 1991a,b; Tamura et al., 1990). To investigate
whether the immune responses induced in mucosal
secretions have virus-neutralizing activity, plaque reduc-
tion assays were performed on MDCK cells. Neutralizing
activity was detected in both saliva (Fig. 6A) and vaginal
secretions (Fig. 6B) after the second boost of the animals.
These neutralizing titers were lower than those observed in
sera (Fig. 3), which is consistent with observations of
other groups (Di Tommaso et al., 1996; Russell et al.,
1996). These data show that mucosal immunization of
CD4+ T cell-deficient mice with inactivated PR8 virus
results in the induction of neutralizing antibodies in
mucosal secretions.Fig. 6. Virus-neutralizing activity in mucosal secretions in CD4+ T cell-
deficient mice. CD4+ T cell-deficient mice were intranasally immunized
with formalin-inactivated influenza virus (50 Ag/mouse per dose, five mice
per group) at day 0 and boosted at days 15 and 25 with the same dose.
Different dilutions of mucosal secretions from immunized mice (pooled
samples from five mice in a group) were incubated with approximately 100
plaque forming unit of PR8 virus for 1 h at room temperature. The mixture
was then applied to monolayers of confluent MDCK cells, and a standard
plaque reduction assay was performed. Representative data were shown
from two independent experiments. CD4/Con, sera from unimmunized
CD4+ T cell-deficient mice. CD4/50/2, CD4+ T cell-deficient mice after
second boost with 50 Ag/mouse per dose. BL6/10/2, C57/BL/6-immuno-
competent mice after second boost with 10 Ag/mouse per dose. (A) Saliva.
(B). Vaginal fluid.
Fig. 7. Protection of CD4+ T cell-deficient mice against live influenza PR8
virus challenge after intranasal immunization with inactivated PR8 virus.
CD4+ T cell-deficient mice (C57BL/6 background) were immunized
intranasally three times with inactivated influenza virus and challenged
with 10 LD50 doses of live influenza virus under anesthesia 4 weeks
after the second boost (four mice per group). Mice were observed daily for
16 days, and all deaths were recorded. *, control, unimmunized CD4+ T
cell-deficient mice. 5, CD4/10, CD4+ T cell-deficient mice immunized
with 10 Ag/mouse per dose of inactivated influenza virus. x, CD4/50,
CD4+ T cell-deficient mice immunized with 50 Ag/mouse per dose of
inactivated influenza virus.
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virus challenge after mucosal immunization with inactivated
virus
To evaluate whether the immune responses elicited by
inactivated PR8 virus after intranasal immunization in CD4+
T cell-deficient mice can protect against live virus challenge,
groups of immunized mice were challenged intranasal with
10 LD50 of live PR8 virus 4 weeks after the second boost.
Results showed that all mice immunized with 10 or 50 Ag/
dose were protected from lethal challenge (Fig. 7). Not only
did these mice survive the challenge, but also minimal signs
of virus infection (decrease of activity, ruffling of fur or
decrease of body weight) were observed in these mice (data
not shown). As expected, most of the unimmunized CD4+ T
cell-deficient mice died around day 8 after challenge. Also,
ah+ T cell-deficient mice were not protected from the same
challenge after three immunizations with 50 Ag of PR8 virus
per dose (survival 0/4). These data indicate that CD4+ T
cell-deficient mice are protected from lethal dose influenza
virus challenge after intranasal immunization with inacti-
vated influenza virus.Discussion
The present study shows that intranasal immunization of
CD4+ T cell-deficient mice with formalin-inactivated PR8
virus induces virus-specific IgG and IgA antibodies in
serum and IgA responses in mucosal secretions. The sera
and mucosal secretions of immunized mice were both found
to have virus-neutralizing activities in vitro, and the immu-
nized CD4+ T cell-deficient mice were also protected from
challenge with a lethal dose of live virus. To our knowledge,
this is the first report demonstrating that mucosal immuni-zation with an inactivated virus can elicit antibody class
switching from IgM to IgG and IgA and induce protective
immune responses in the absence of CD4+ T cells.
It is important to induce mucosal immunity since the
majority of infectious agents enter their host through a
mucosal surface. However, very little is known concerning
immune responses induced by mucosal delivery of non-
infectious virus particles in a CD4+ T cell-deficient
condition. Here, we found several differences between
immune responses induced by intranasal immunization
compared to those by systemic immunization in CD4+ T
cell-deficient mice. The most prominent difference is the
induction of serum and mucosal IgA antibody by intra-
nasal immunization, which could not be detected following
systemic immunization (Sha and Compans, 2000). Second,
intranasal immunization required relatively a high dose (50
Ag per mouse) of inactivated influenza virus for induction
of IgG antibodies in the absence of CD4+ T cells and the
responses were lower than those observed in wild-type
mice. Since CD4+ T cell-deficient mice are known to have
normal B cell functions in response to lipopolysaccharide
indicating no intrinsic defect of B cells, and they exhibit
comparable levels of total IgG or IgA expressing B cells as
compared with normal mice (Hornquist et al., 1995;
Rahemtulla et al., 1991), it is likely that there might be
a defect in antigen-specific B cell activation or antigen-
specific Ig production from mice lacking conventional
CD4 T cells particularly after intranasal (this study) or oral
immunization (Hornquist et al., 1995). In contrast,
systemic immunization with low doses of inactivated
influenza virus in CD4+ T cell-deficient mice induced
comparable levels of IgG antibodies to those induced in
normal mice (Sha and Compans, 2000). Third, two
boosting immunizations were needed for induction of
neutralizing antibodies by intranasal immunization in the
absence of CD4+ T cells, whereas one boost was sufficient
to induce neutralizing antibodies in systemic immunization
of CD4+ T cell-deficient mice. Therefore, there are
qualitative and quantitative differences in immune
responses between mucosal and systemic immunization
of CD4+ T cell-deficient mice.
Inactivated influenza virus seems to be uniquely effective
as an immunogen. In previous studies of CD4+ T cell-
deficient mice using cholera toxin (CT) as a mucosal
immunogen, low levels of antigen-specific mucosal IgA
antibody were observed following oral immunization, but
the immunized mice remained unprotected against CT-
induced diarrhea (Hornquist et al., 1995). Our study
demonstrates that intranasal immunization of CD4+ T cell-
deficient mice with inactivated influenza virus could induce
neutralizing antibodies in secretions and provide protection
against lethal viral challenge. Taken together, these results
suggest that inactivated influenza virus may be a more
effective immunogen than CT at inducing mucosal immun-
ity in the absence of CD4+ T cells, although different routes
of immunization were used.
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on the cognate interaction between CD4+ T helper cells and
B cells and the cytokines released by the activated CD4+ T
cells (Finkelman et al., 1990; Oxenius et al., 1998; Parker,
1993; Snapper and Mond, 1993). However, some studies
have shown the T cell-independent induction of IgG
antibodies in animals infected with certain live viruses
(Maloy et al., 1998; Rahemtulla et al., 1994; Szomolanyi-
Tsuda and Welsh, 1998; Szomolanyi-Tsuda et al., 1998;
Viney et al., 1994). Also, it was demonstrated that Rag 1
and Rag 2 knockout mice, which lack both T and B cells,
chronically shed 100-fold higher levels of rotavirus antigen
than mice lacking only CD4(+) T cell help (VanCott et al.,
2001), suggesting that the production of T cell-independent
antibody to rotavirus could substantially reduce rotavirus
shedding. Polyomavirus infection of ah+ T cell-deficient
mice or ah+ and gy+ T cell-deficient mice elicited a
protective, T cell-independent IgG response in serum,
indicating that neither ah+ nor gy+ T cells are required in
this process; however, no IgG responses were elicited by
immunization of these mice with polyoma virus-like
particles or purified viral protein VP1 (Szomolanyi-Tsuda
et al., 1998). In studies with VSV, ah+ T cell-deficient mice
produced neutralizing IgG antibodies when infected with
live VSV or with a recombinant vaccinia virus expressing
the VSV glycoprotein, but not when immunized with
inactivated VSV (Maloy et al., 1998). In the present study,
ah+ T cell-deficient mice were not observed to produce
significant amounts of IgG antibodies upon mucosal
immunization with formalin-inactivated PR8 virus. There-
fore, signals generated by live virus infection may be
essential for induction of IgG antibodies in the absence of
ah+ T cells.
It has been suggested that CD4 and CD8 double-
negative ah-T cells (DN T cells) that are present in the
CD4+ gene-targeted mice play a role in inducing Ig class
switching and antigen-specific IgG responses to some
antigens (Hornquist et al., 1995; Locksley et al., 1993;
Rahemtulla et al., 1994; Sha and Compans, 2000). CD4+
gene-targeted mice were found to have numerous B cell
germinal centers in Peyer’s patches and gut-associated
lymphoid tissues where DN T cells were co-localized
(Hornquist et al., 1995). We also found that such DN T
cells constitute about 30% of the total T cell population in
6-month-old CD4+ T-cell deficient mice and about 15% in
younger (6-week-old) mice (Sha and Compans, 2000). In
contrast, in normal mice, DN T cells represent a very
minor population of less than 2% (Sha and Compans,
2000) and seem to differ from DN T cells in CD4+ gene-
targeted mice (Locksley et al., 1993; Rahemtulla et al.,
1994). In support of this idea, when C57BL/6 mice were
depleted of CD4+T cells with an anti-CD4 antibody, their
ability to generate IgG antibodies after immunization with
inactivated influenza virus was abrogated (unpublished
observations), indicating that a compensatory mechanism
(DN T cells) develops in the congenitally CD4+ T cell-deficient mice that is not present in the acutely CD4+ T
cell-depleted mice.
In summary, the present results indicate that mucosal
immunization with a nonreplicating viral antigen can induce
neutralizing antibodies and provide protective immune
responses even in the absence of normal CD4+ T cells.
This finding may have important clinical implications,
especially for immunization of immunocompromised
patients against infections initiated at mucosal surfaces.Materials and methods
Animals
C57BL/6J mice, C57BL/6-Cd4tm1Mak that had a targeted
disruption in their CD4 gene, thus, did not express CD4 on
cell surfaces, and lacked functional CD4+T cells (Rahem-
tulla et al., 1991) and C57BL/6J-Tcrbtm1Mom that had a
targeted disruption in their TCRh gene and lacked func-
tional ah T cells (Mombaerts et al., 1992), were obtained
from Jackson Laboratory (Bar Harbor, ME). Some of the
mice were bred in the Department of Animal Resources in
Emory University from purchased breeding pairs. Since it
was demonstrated that older CD4+ T cell knockout mice
produced higher levels of antibody responses (Sha and
Compans, 2000), 16- to 20-week-old CD4+ T cell-deficient
mice and 10-week-old C57BL/6-immunocompetent mice
were used in this study.
Virus
Embryonated hen’s eggs (9–11 days old) were used to
grow influenza virus A/PR8/34 in the allantoic cavity. Virus
was purified from allantoic fluid by sucrose gradient (30–
60%) centrifugation at 100000  g for 3 h (Novak et al.,
1993). Inactivation of the purified virus was performed by
mixing the virus with formalin at a final concentration at
1:4000 (v/v). The mixture was incubated at 37 8C for 72 h
and then dialyzed against PBS with three changes (Novak et
al., 1993; Sha and Compans, 2000). The virus stock was
stored in aliquots at 80 8C before use. Inactivation of the
virus was confirmed by both plaque assay on confluent
monolayer MDCK cells and inoculation of the virus into 9-
to 11-day-old embryonated hen’s eggs.
Immunization and sampling
Mice (five mice per group) were immunized with 1, 10,
or 50 Ag of inactivated influenza virus in 100 Al PBS
intranasally (in) at days 0, 15, and 25. Blood samples were
collected 15 days after priming and 10 days after each boost.
Anesthetized mice were bled from retro-orbital veins to
obtain blood samples. Samples were centrifuged at 14000
rpm for 15 min twice and sera were stored at 20 8C. Saliva
was collected by aspiration from the cheek pouch after
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tongue to stimulate flow in mice, and phenylmethylsulfonyl
fluoride (PMSF) in isopropanol (100 mM) was added to the
saliva at a final concentration of 1 mM as a protease
inhibitor (Russell et al., 1996). Vaginal fluids were collected
by flushing the mouse vaginal cavity with 100 Al PBS back
and forth 20 times with a blunt-tipped feeding needle;
approximately 70 Al of fluid was recovered from each
mouse.
Virus neutralization assay
A plaque reduction assay was performed to demonstrate
the PR8 virus-specific neutralizing titer of the sera and
mucosal secretions as previously described (Sha and
Compans, 2000). Briefly, approximately 100 plaque-form-
ing units (PFU) of influenza A/PR8 virus in 200 Al 1
DMEM medium was mixed with sera at 5-, 20-, 100-, or
500-fold dilutions (or mixed with saliva or vaginal
secretions at 10-, 20-, 40-, or 80-fold dilutions) and
incubated at room temperature for 1 h. Aliquots of 200 Al
were added onto confluent MDCK cell monolayers in 6-
well plates, the plates were incubated at 37 8C for 1 h and
shaken gently every 15 min. The inocula were removed,
cells were washed once with 1 DMEM medium, then
1.95% white agar in 1 DMEM medium containing 1 Ag
trypsin was overlaid on the cells. The plates were incubated
at 37 8C for 4 days, stained with neutral red, and plaques in
each well were counted. The neutralizing antibody titer was
considered as the highest dilution of the serum or mucosal
secretions that was found to reduce the number of plaques
by at least 50%.
Antibody responses
Enzyme-linked immunosorbent assay (ELISA) was used
to determine the levels of influenza virus-specific antibodies
as described (Pertmer et al., 1996). Briefly, flat-bottom 96-
well plates (Dynatech, Alexandria, VA) were coated with
purified PR8 virus in borate-buffered saline (BBS) at a
concentration of 2 Ag/ml. After blocking the plates with
PBS with 1% BSA, different dilutions of serum, saliva, or
vaginal secretions were added to the plates and incubated
overnight. The plates were then incubated with horseradish
peroxidase-labeled goat anti-mouse IgG or IgA (Southern
Biotechnology Associates, Birmingham, AL). After wash-
ing, the substrate 2,2’-azino-bis-[3-ethylbenzthiazoline sul-
fonic acid] (ABTS) (Sigma, St. Louis, MO) in phosphate
citrate buffer (3 mg/10 ml) (pH 4.2) containing 0.03% H2O2
was added. After 10- to 20-min incubation at room
temperature in the dark, absorbance was measured by an
ELISA reader at 405 nm. For determination of the relative
levels of PR8-specific IgA and IgG subclass responses, a
quantitative assay was performed. Standard curves were
obtained as follows: purified mouse IgG1, IgG2a, IgG2b,
IgG3, or IgA was added to plates precoated with goat anti-mouse Ig(H + L) antibody, then HRP-conjugated goat
antibodies against IgA or each IgG subclass were added and
colors were developed with ABTS substrate. Concentrations
of IgG1, IgG2a, IgG2b, IgG3, and IgA were determined by
comparing the reading of the experimental samples with
the standard curves, and are represented as the arithmetic
mean F1 standard error. The statistical analysis of differ-
ences between groups was carried out by the Excel program.
Challenge studies
The lethal dose 50 (LD50) in CD4+ T cell-deficient mice
for PR8 virus was previously found to be comparable with
the LD50 in normal C57BL/6 mice (Sha and Compans,
2000). Challenge experiments were performed as described
by Nguyen et al. (1999). Briefly, a mouse adapted antigeni-
cally identical strain of A/PR8/34 (provided by Dr. Jiri
Mestecky, University of Alabama, Birmingham) was used
for intranasal inoculation. 10 LD50 (500 PFU) of virus
was administered by instillation into the nostrils of the
anesthetized mice in a volume of 50 Al. Mice were observed
daily for 16 days, and all deaths were recorded.Acknowledgments
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